The two new antirheumatic agents are useful, effective and well tolerated drugs and compared favourably with Phenylbutazone and Indomethacin which are generally much less tolerated and not for long without creating dyspepsia especially. Flufenamic acid is effective but least tolerated. Perhaps in combination with others it may prove more efficacious. The new drugs will therefore, in the long run prove more useful in rheumatoid arthritis, where prolonged maintenance therapy is required. Gold in selected cases is very useful but must be given under strict supervision of an experienced physician.